fda glp-1 compounding enforcement news october 2025 Last month, the issued 25 warning letters to telehealth companies over what it called false or misleading claims about compounded medications FDA is moving to restrict

Novo Nordisk plans to present details of its study, called ORION, at the Obesity Medicine Associations annual Obesity Medicine 2026 conference, set for April 10-12 in San Diego

No strict diet is required, but eating smaller, balanced meals helps maximize your results

How Do You Use Glutathione in Your Skincare Routine

Results Subjects characteristics A total of 50 subjects out of 58 were recruited and completed the study, with a response rate of 89.7%

Potential for longer healthspan: Because GLP-1 drugs can reduce risk factors for chronic diseases (like diabetes, heart disease, and possibly neurodegenerative diseases), they could help people stay healthier for longer as they age

This may be especially true early on or after a dose change